STTK
Shattuck Labs, Inc.
Price Chart
Latest Quote
$4.95
+0.21 (+4.43%)
Current Price
| Previous Close | $4.74 |
| Open | $4.85 |
| Day High | $5.08 |
| Day Low | $4.73 |
| Volume | 1,221,914 |
Stock Information
| Shares Outstanding | 95.51M |
| Total Debt | $2.89M |
| Cash Equivalents | $90.42M |
| Revenue | $1.00M |
| Net Income | $-49.87M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $472.77M |
| EPS (TTM) | $-0.56 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $244.50M |
| Sales | $1.00M |
| Income | $-49.87M |
| Book/sh | $1.27 |
| Cash/sh | $0.95 |
| Employees | 40 |
Financial Ratios
| Quick Ratio | 21.28 |
| Current Ratio | 22.07 |
| Debt/Eq | 3.02 |
Returns & Margins
| ROA | -36.66% |
| ROE | -61.04% |
| Gross Margin | -297.80% |
| Operating Margin | -5258.30% |
Ownership
| Insider Ownership | 4.53% |
| Institutional Ownership | 53.86% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -9.60 |
| P/S | 472.77 |
| P/B | 3.90 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $14.83 |
Technical Indicators
| SMA20 | $5.05 |
| SMA50 | $6.21 |
| SMA200 | $4.13 |
| RSI | 39.36 |
| ATR | 0.6026 |
| Shares Float | 52.60M |
| Short Float | 1.57% |
| Short Ratio | 1.95 |
| Volatility | 1.09 |
| Rel Volume | 1.11 |
Performance History
| Week | +18.42% |
| Month | -14.51% |
| Quarter | -18.85% |
| 6 Months | +68.37% |
| YTD | +33.42% |
| Year | +409.26% |
| 3 Years | +80.66% |
| 5 Years | -83.41% |
| 10 Years | -74.42% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $4.95 | 1,221,900 |
| 2026-06-17 | $4.74 | 743,500 |
| 2026-06-16 | $4.33 | 642,300 |
| 2026-06-15 | $4.63 | 945,700 |
| 2026-06-12 | $4.94 | 1,288,700 |
| 2026-06-11 | $4.18 | 940,400 |
| 2026-06-10 | $4.13 | 2,174,500 |
| 2026-06-09 | $4.27 | 1,461,400 |
| 2026-06-08 | $3.90 | 5,579,700 |
| 2026-06-05 | $4.58 | 1,134,100 |
| 2026-06-04 | $4.80 | 405,100 |
| 2026-06-03 | $4.75 | 370,200 |
| 2026-06-02 | $4.87 | 831,200 |
| 2026-06-01 | $5.65 | 713,800 |
| 2026-05-29 | $5.95 | 1,044,000 |
| 2026-05-28 | $5.97 | 321,400 |
| 2026-05-27 | $6.06 | 318,500 |
| 2026-05-26 | $6.11 | 440,100 |
| 2026-05-22 | $6.10 | 338,700 |
| 2026-05-21 | $6.09 | 1,014,700 |
| 2026-05-20 | $6.17 | 307,600 |
| 2026-05-19 | $5.79 | 625,000 |
About Shattuck Labs, Inc.
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
đ° Latest News
We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate
Simply Wall St. âĸ 2026-05-11T11:33:48Z
Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)
Insider Monkey âĸ 2026-05-01T08:17:52Z
Why Shattuck Labs Stock Soared More Than 53% Higher This Week
Motley Fool âĸ 2026-03-06T22:02:08Z
Why Shattuck Labs Stock Soared in December
Motley Fool âĸ 2026-01-06T03:50:09Z
Several Insiders Invested In Shattuck Labs Flagging Positive News
Simply Wall St. âĸ 2026-01-05T13:13:43Z
Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Result
Insider Monkey âĸ 2025-11-29T06:26:14Z
Hedge funds own 27% of Shattuck Labs, Inc. (NASDAQ:STTK) shares but individual investors control 32% of the company
Simply Wall St. âĸ 2025-11-25T10:39:53Z
What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?
Zacks âĸ 2025-10-08T16:00:04Z
Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?
Zacks âĸ 2025-09-19T13:55:01Z
Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock?
Zacks âĸ 2025-09-08T21:09:53Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $1,000,000 | $5,721,000 | $1,657,000 | $652,000 |
| Operating Revenue | $1,000,000 | $5,721,000 | $1,657,000 | $652,000 |
| Expenses | ||||
| Total Expenses | $52,508,000 | $86,288,000 | $93,614,000 | $103,981,000 |
| Other Income Expense | $-4,000 | $-17,000 | $-10,000 | $-208,000 |
| Other Non Operating Income Expenses | $-4,000 | $-17,000 | $-10,000 | $-208,000 |
| Net Non Operating Interest Income Expense | $2,703,000 | $5,174,000 | $4,669,000 | $1,592,000 |
| Operating Expense | $52,508,000 | $86,288,000 | $93,614,000 | $103,981,000 |
| General And Administrative Expense | $17,235,000 | $19,077,000 | $19,304,000 | $21,082,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Net Interest Income | $2,703,000 | $5,174,000 | $4,669,000 | $1,592,000 |
| Interest Income | $2,703,000 | $5,174,000 | $4,669,000 | $1,592,000 |
| Normalized Income | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Net Income From Continuing And Discontinued Operation | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Total Operating Income As Reported | $-51,508,000 | $-80,567,000 | $-91,957,000 | $-103,329,000 |
| Net Income Common Stockholders | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Net Income | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Net Income Including Noncontrolling Interests | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Net Income Continuous Operations | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Pretax Income | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Interest Income Non Operating | $2,703,000 | $5,174,000 | $4,669,000 | $1,592,000 |
| Operating Income | $-51,508,000 | $-80,567,000 | $-91,957,000 | $-103,329,000 |
| Per Share | ||||
| Diluted EPS | $-0.70 | $-1.49 | $-2.05 | $-2.41 |
| Basic EPS | $-0.70 | $-1.49 | $-2.05 | $-2.41 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-47,820,000 | $-76,738,000 | $-87,915,000 | $-100,256,000 |
| Reconciled Depreciation | $3,688,000 | $3,829,000 | $4,042,000 | $3,073,000 |
| EBITDA (Bullshit earnings) | $-47,820,000 | $-76,738,000 | $-87,915,000 | $-100,256,000 |
| EBIT | $-51,508,000 | $-80,567,000 | $-91,957,000 | $-103,329,000 |
| Diluted Average Shares | $69,584,937 | $50,758,290 | $42,600,190 | $42,378,895 |
| Basic Average Shares | $69,584,937 | $50,758,290 | $42,600,190 | $42,378,895 |
| Diluted NI Availto Com Stockholders | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Research And Development | $35,273,000 | $67,211,000 | $74,310,000 | $82,899,000 |
| Selling General And Administration | $17,235,000 | $19,077,000 | $19,304,000 | $21,082,000 |
| Other Gand A | $17,235,000 | $19,077,000 | $19,304,000 | $21,082,000 |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $82,390,000 | $79,626,000 | $144,705,000 | $176,157,000 |
| Total Assets | $91,026,000 | $91,049,000 | $159,564,000 | $205,324,000 |
| Total Non Current Assets | $8,551,000 | $11,834,000 | $16,344,000 | $20,740,000 |
| Other Non Current Assets | $1,437,000 | $2,022,000 | $2,540,000 | $3,069,000 |
| Current Assets | $82,475,000 | $79,215,000 | $143,220,000 | $184,584,000 |
| Other Current Assets | $4,410,000 | $6,228,000 | $12,595,000 | $23,304,000 |
| Cash Cash Equivalents And Short Term Investments | $78,065,000 | $72,987,000 | $130,625,000 | $161,280,000 |
| Cash And Cash Equivalents | $54,192,000 | $57,387,000 | $125,626,000 | $47,379,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $2,421,000 | $3,406,000 | $4,202,000 | $4,903,000 |
| Long Term Debt And Capital Lease Obligation | $1,584,000 | $2,506,000 | $3,406,000 | $4,202,000 |
| Current Debt And Capital Lease Obligation | $837,000 | $900,000 | $796,000 | $701,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,636,000 | $11,423,000 | $14,859,000 | $29,167,000 |
| Total Non Current Liabilities Net Minority Interest | $1,584,000 | $2,506,000 | $3,406,000 | $4,202,000 |
| Current Liabilities | $7,052,000 | $8,917,000 | $11,453,000 | $24,965,000 |
| Other Current Liabilities | $236,000 | $410,000 | $1,041,000 | $1,871,000 |
| Payables And Accrued Expenses | $3,212,000 | $5,319,000 | $5,822,000 | $18,426,000 |
| Payables | $2,101,000 | $2,419,000 | $1,587,000 | $7,170,000 |
| Accounts Payable | $2,101,000 | $2,419,000 | $1,587,000 | $7,170,000 |
| Non Current Deferred Liabilities | - | - | - | $0 |
| Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $82,390,000 | $79,626,000 | $144,705,000 | $176,157,000 |
| Total Equity Gross Minority Interest | $82,390,000 | $79,626,000 | $144,705,000 | $176,157,000 |
| Stockholders Equity | $82,390,000 | $79,626,000 | $144,705,000 | $176,157,000 |
| Gains Losses Not Affecting Retained Earnings | $6,000 | $2,000 | $4,000 | $-877,000 |
| Other Equity Adjustments | $6,000 | $2,000 | $4,000 | $-877,000 |
| Retained Earnings | $-430,529,000 | $-381,720,000 | $-306,310,000 | $-219,012,000 |
| Long Term Equity Investment | $1,000,000 | $0 | - | - |
| Other | ||||
| Ordinary Shares Number | $63,279,843 | $47,714,708 | $47,260,108 | $42,390,586 |
| Share Issued | $63,279,843 | $47,714,708 | $47,260,108 | $42,390,586 |
| Tangible Book Value | $82,390,000 | $79,626,000 | $144,705,000 | $176,157,000 |
| Invested Capital | $82,390,000 | $79,626,000 | $144,705,000 | $176,157,000 |
| Working Capital | $75,423,000 | $70,298,000 | $131,767,000 | $159,619,000 |
| Capital Lease Obligations | $2,421,000 | $3,406,000 | $4,202,000 | $4,903,000 |
| Total Capitalization | $82,390,000 | $79,626,000 | $144,705,000 | $176,157,000 |
| Additional Paid In Capital | $512,906,000 | $461,339,000 | $451,006,000 | $396,041,000 |
| Capital Stock | $7,000 | $5,000 | $5,000 | $5,000 |
| Common Stock | $7,000 | $5,000 | $5,000 | $5,000 |
| Long Term Capital Lease Obligation | $1,584,000 | $2,506,000 | $3,406,000 | $4,202,000 |
| Current Capital Lease Obligation | $837,000 | $900,000 | $796,000 | $701,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,767,000 | $2,288,000 | $3,794,000 | $3,967,000 |
| Current Accrued Expenses | $1,111,000 | $2,900,000 | $4,235,000 | $11,256,000 |
| Investments And Advances | $1,000,000 | $0 | - | - |
| Net PPE | $6,114,000 | $9,812,000 | $13,804,000 | $17,671,000 |
| Accumulated Depreciation | $-16,674,000 | $-13,217,000 | $-9,506,000 | $-5,709,000 |
| Gross PPE | $22,788,000 | $23,029,000 | $23,310,000 | $23,380,000 |
| Leases | $6,877,000 | $7,097,000 | $7,097,000 | $7,086,000 |
| Other Properties | $15,267,000 | $15,288,000 | $15,469,000 | $15,547,000 |
| Machinery Furniture Equipment | $644,000 | $644,000 | $644,000 | $643,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $23,873,000 | $15,600,000 | $4,999,000 | $113,901,000 |
| Construction In Progress | - | $0 | $100,000 | $104,000 |
| Non Current Deferred Revenue | - | - | - | - |
| Current Deferred Revenue | - | - | - | - |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-39,953,000 | $-60,574,000 | $-81,635,000 | $-106,112,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-39,882,000 | $-60,515,000 | $-81,228,000 | $-94,498,000 |
| Cash Flow From Continuing Operating Activities | $-39,882,000 | $-60,515,000 | $-81,228,000 | $-94,498,000 |
| Operating Gains Losses | $81,000 | $222,000 | $303,000 | $704,000 |
| Investing Activities | ||||
| Capital Expenditure | $-71,000 | $-59,000 | $-407,000 | $-11,614,000 |
| Investing Cash Flow | $-7,887,000 | $-8,511,000 | $110,859,000 | $49,438,000 |
| Cash Flow From Continuing Investing Activities | $-7,887,000 | $-8,511,000 | $110,859,000 | $49,438,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $44,475,000 | - | $48,170,000 | $0 |
| Financing Cash Flow | $44,574,000 | $787,000 | $48,616,000 | $171,000 |
| Cash Flow From Continuing Financing Activities | $44,574,000 | $787,000 | $48,616,000 | $171,000 |
| Net Other Financing Charges | $-65,000 | $-451,000 | $-53,000 | - |
| Net Common Stock Issuance | $44,475,000 | $-17,000 | $48,170,000 | $0 |
| Common Stock Issuance | $44,475,000 | - | $48,170,000 | $0 |
| Repurchase Of Capital Stock | - | $-17,000 | - | - |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| End Cash Position | $54,192,000 | $57,387,000 | $125,626,000 | $47,379,000 |
| Beginning Cash Position | $57,387,000 | $125,626,000 | $47,379,000 | $92,268,000 |
| Changes In Cash | $-3,195,000 | $-68,239,000 | $78,247,000 | $-44,889,000 |
| Proceeds From Stock Option Exercised | $164,000 | $1,255,000 | $499,000 | $171,000 |
| Net Investment Purchase And Sale | $-7,816,000 | $-8,452,000 | $111,266,000 | $60,948,000 |
| Sale Of Investment | $35,600,000 | $85,100,000 | $190,999,000 | $193,325,000 |
| Purchase Of Investment | $-43,416,000 | $-93,552,000 | $-79,733,000 | $-132,377,000 |
| Net PPE Purchase And Sale | $-71,000 | $-59,000 | $-407,000 | $-11,510,000 |
| Purchase Of PPE | $-71,000 | $-59,000 | $-407,000 | $-11,614,000 |
| Change In Working Capital | $-785,000 | $3,021,000 | $-4,095,000 | $-4,464,000 |
| Change In Other Current Liabilities | $-922,000 | $-900,000 | $-796,000 | $-702,000 |
| Change In Other Current Assets | $79,000 | $90,000 | $165,000 | $-53,000 |
| Change In Payables And Accrued Expense | $-1,760,000 | $-2,536,000 | $-13,922,000 | $133,000 |
| Change In Accrued Expense | $-1,442,000 | $-3,368,000 | $-8,293,000 | $2,975,000 |
| Change In Payable | $-318,000 | $832,000 | $-5,629,000 | $-2,842,000 |
| Change In Account Payable | $-318,000 | $832,000 | $-5,629,000 | $-2,842,000 |
| Change In Prepaid Assets | $1,818,000 | $6,367,000 | $10,458,000 | $-3,842,000 |
| Other Non Cash Items | $-599,000 | $428,000 | $364,000 | $302,000 |
| Stock Based Compensation | $6,995,000 | $9,546,000 | $6,939,000 | $6,462,000 |
| Amortization Of Securities | $-453,000 | $-2,151,000 | $-1,483,000 | $1,370,000 |
| Depreciation Amortization Depletion | $3,688,000 | $3,829,000 | $4,042,000 | $3,073,000 |
| Depreciation And Amortization | $3,688,000 | $3,829,000 | $4,042,000 | $3,073,000 |
| Depreciation | $3,688,000 | $3,829,000 | $4,042,000 | $3,073,000 |
| Net Income From Continuing Operations | $-48,809,000 | $-75,410,000 | $-87,298,000 | $-101,945,000 |
| Common Stock Payments | - | $-17,000 | - | - |
| Sale Of PPE | - | - | $0 | $104,000 |
| Change In Other Working Capital | - | - | $343,000 | - |
Fetched: 2026-06-16